Bleeding risks of antithrombotic therapy

BMJ. 2002 Oct 12;325(7368):828-31. doi: 10.1136/bmj.325.7368.828.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects
  • Aspirin / adverse effects
  • Fibrinolytic Agents / adverse effects*
  • Hemorrhage / chemically induced*
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Risk Factors
  • Thrombosis / drug therapy*
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Aspirin